Download Medical Notes on Evaluate Vantage 2020 Preview – A Report on Pharmaceutical Industry

Evaluate Vantage 2020 Preview – A Report on Pharmaceutical Industry Medical Notes

About This Presentation

Description:The Evaluate Vantage 2020 Preview is a report on pharmaceutical industry and predicts a good year ahead. The year ahead promises significant growth contrasting with investor uncertainty. The pharmaceutical industry concluded the year 2019 on a high note. Areas like cancer, vaccines and diabetes are all set to continue this with strong sales in the year 2020. The report talks about the US political scene and issues around drug pricing, investor uncertainty, the US FDA’s industry-friendly stance, Abbvie’s Humira prospects to be 2020’s biggest seller, Merck & Co’s Keytruda’s prospects of growth, Trastuzumab deruxtecan (Daiichi Sankyo / AstraZeneca) being 2020’s most lucrative potential approval, AstraZeneca’s prospects to be the fastest growing drug company in 2020, etc.

Tags:Pharmaceutical Industry, report on pharmaceutical industry, pharmaceutical, cancer, vaccines, diabetes

Published on: Jun 29, 2020 | Views : 2009 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 5

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 5

Cancer Medicines: Value in Context

Taming big Pharma

Indian Healthcare Industry Analysis by IBEF

Generic Drug Program Update

The Global Use of Medicine in 2019 and Outlook to 2023

EvaluatePharma Orphan Drug Report 2020

Taming big Pharma

Granulation

The Impact of the COVID-19 Pandemic on Global Pharmaceutical Growth

HEALTH A TO Z